Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp)

por Javle, M.M., Oh, D.-Y., Ikeda, M., Yong, W.-P., Hsu, K., Lindmark, B., McIntyre, N., Firth, C.
Publicado 2021